William Blair Increases Earnings Estimates for Trupanion

Trupanion, Inc. (NASDAQ:TRUP - Free Report) - Equities researchers at William Blair increased their FY2024 EPS estimates for Trupanion in a report issued on Wednesday, October 30th. William Blair analyst B. Vazquez now expects that the financial services provider will post earnings of ($0.13) per share for the year, up from their prior estimate of ($0.17). William Blair currently has a "Outperform" rating on the stock. The consensus estimate for Trupanion's current full-year earnings is ($0.34) per share. William Blair also issued estimates for Trupanion's Q4 2024 earnings at $0.14 EPS, Q1 2025 earnings at ($0.03) EPS, Q1 2026 earnings at $0.01 EPS and Q2 2026 earnings at $0.00 EPS.

Several other brokerages have also recently issued reports on TRUP. Stifel Nicolaus boosted their price target on shares of Trupanion from $30.00 to $40.00 and gave the company a "hold" rating in a research report on Monday, September 23rd. Evercore ISI raised Trupanion to a "strong-buy" rating in a research report on Friday, August 9th. Bank of America lifted their price target on Trupanion from $47.00 to $56.00 and gave the company a "buy" rating in a research report on Friday, September 20th. Piper Sandler increased their price objective on Trupanion from $45.00 to $57.00 and gave the stock a "neutral" rating in a report on Thursday. Finally, Northland Securities upped their target price on shares of Trupanion from $45.00 to $50.00 and gave the stock a "market perform" rating in a research report on Thursday. Four investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $44.67.

Trupanion Trading Down 8.3 %

TRUP stock traded down $4.51 on Monday, reaching $50.05. The company's stock had a trading volume of 887,291 shares, compared to its average volume of 681,995. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.63 and a current ratio of 1.66. Trupanion has a 12-month low of $19.69 and a 12-month high of $57.90. The firm has a market cap of $2.11 billion, a PE ratio of -157.22 and a beta of 1.69. The business has a fifty day simple moving average of $47.08 and a two-hundred day simple moving average of $36.43.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The business had revenue of $327.50 million during the quarter, compared to analysts' expectations of $321.79 million. During the same quarter last year, the business posted ($0.10) EPS. The business's revenue was up 14.6% on a year-over-year basis.

Insider Transactions at Trupanion

In other news, CEO Margaret Tooth sold 7,500 shares of Trupanion stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total value of $348,600.00. Following the completion of the transaction, the chief executive officer now owns 99,984 shares of the company's stock, valued at $4,647,256.32. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Margaret Tooth sold 7,500 shares of the firm's stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $46.48, for a total transaction of $348,600.00. Following the completion of the sale, the chief executive officer now owns 99,984 shares of the company's stock, valued at $4,647,256.32. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Fawwad Qureshi sold 624 shares of the company's stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The disclosure for this sale can be found here. Over the last three months, insiders have sold 8,764 shares of company stock valued at $405,238. Insiders own 5.50% of the company's stock.

Institutional Investors Weigh In On Trupanion

Several large investors have recently bought and sold shares of TRUP. GAMMA Investing LLC boosted its holdings in shares of Trupanion by 70.4% during the 3rd quarter. GAMMA Investing LLC now owns 1,442 shares of the financial services provider's stock valued at $61,000 after acquiring an additional 596 shares during the last quarter. Headlands Technologies LLC purchased a new stake in Trupanion in the second quarter worth approximately $162,000. Handelsbanken Fonder AB bought a new stake in Trupanion in the 3rd quarter worth approximately $248,000. Oppenheimer Asset Management Inc. purchased a new stake in Trupanion during the 2nd quarter valued at $235,000. Finally, Sigma Planning Corp bought a new position in shares of Trupanion during the 3rd quarter valued at $336,000.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.